ebulized magnesium sulfate treatment in acute exacerbation of chronic obstructive pulmonary disease
- Conditions
- Chronic obstructive pulmonary disease with acute exacerbation.Chronic obstructive pulmonary disease with acute exacerbation, unspecified
- Registration Number
- IRCT2016012420024N3
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
1.Known history of chronic obstructive pulmonary disease (COPD) based on previous clinical history and spirometry;
2.Presentating to emergency department with at least two of following symptoms: shortness of breath, increase in the amount of sputum and/or purulent pattern of the sputum;
3.Age>40 years;
4.within 24 h of hospital admission;
5.smoking history > 20 pack.year;
1.Patient with unstable vital signs;
2.Intubated patient;
3.Associated comorbidity (pneumothorax, pulmonary embolism, pneumonia, acute coronary syndrome, congestive heart failure, neuromuscular disease, active malignancy and etc.);
4.Unconscious patient;
5.Inability to perform spirometry;
6.Nursing/pregnant women;
7.Previous history of allergy to magnesium sulfate;
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ung volumes. Timepoint: Just before the Magnesium Sulfate/Placebo and again after 90 minutes of administration. Method of measurement: COSMED spirometer.;Arterial oxygen saturation of hemoglobin. Timepoint: Just before the Magnesium Sulfate/Placebo and again after 90 minutes of administration. Method of measurement: Pulse oximeter - Beurer.;COPD Assessment Test (CAT) questionnaire, persian version. Timepoint: Just before the Magnesium Sulfate/Placebo and again after 90 minutes of administration. Method of measurement: CAT score.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: Discharge documents. Method of measurement: Days of admission.